WHO: More Hepatitis C Patients Being Treated In Developing Countries; Price Still An Issue 27/10/2016 by Catherine Saez, Intellectual Property Watch 2 Comments Innovations in medicine bring the hope of cure for millions of patients who can access them. When a novel effective hepatitis C drug was put on the market at very high prices, concerns erupted about access in both developing and developed countries. A new report by the World Health Organization found that over one million people have received new treatment for hepatitis C in developing countries. The report, which targets high prices as a major barrier to access to treatment, also compiles ways countries have overcome the access barriers.
Protecting Online Access To Safe And Affordable Medication 27/10/2016 by Intellectual Property Watch Leave a Comment High drug prices are a global public health crisis. This is mostly the case among lower income countries but also for citizens and residents in the US, where tens of millions are not filling prescriptions due to cost. The international online marketplace is a much-needed lifeline for consumers who cannot afford prescription medication where they live. People deserve the widest possible access to safe and affordable medication, including online access, and the Internet community can help, says Gabriel Levitt.
Between Quick Wins And Long Roads Ahead On Antimicrobial Resistance 26/10/2016 by Alexandra Nightingale for Intellectual Property Watch Leave a Comment Raising awareness, creating effective stewardship, national action plans on antimicrobial resistance, building trust and getting onto the agenda of the G20 are critical to fostering access and appropriate use of antibiotics, according to speakers at yesterday’s joint technical symposium on antimicrobial resistance (AMR).
Antimicrobial Resistance Should Not Overshadow Broader Issue Of Access To Medicines, Some Say 26/10/2016 by Catherine Saez, Intellectual Property Watch 1 Comment While the issue of antimicrobial resistance has arrived in high-level discussions, and there is a consensus that the problem must be tackled one way or another to avoid slipping back into a pre-antibiotic era, some voices are highlighting the need to remember that other health issues remain unmet, and access to medicines is still an acute problem.
Antimicrobial Resistance Needs Research, Regulation, Speakers Say 26/10/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment The issue of antimicrobial resistance has been in the spotlight in recent months as a growing awareness of the threat it represents for humanity has pushed discussions at the multilateral level. This week, the World Health Organization, World Intellectual Property Organization and World Trade Organization organised a symposium on the subject. Speakers discussed needs and potential solutions.
‘WHO Is Not Just Seeking To Be A Firefighter’ – Peter Salama On Reform And Emergency Response At The UN Health Agency 26/10/2016 by William New, Intellectual Property Watch Leave a Comment Under its new health emergencies program, the World Health Organization is setting up an improved structure for global health emergencies like the Ebola outbreak. But the UN agency is also opening itself up to a role as partnership broker to ensure the world has what it needs when the emergencies arise. And in doing so, WHO is trying to ensure that it remains the central player in global policy discussions and is not just an emergency response unit.
WHO, WTO, WIPO Put Their Collective Mind To Antibiotic Resistance Calamity 25/10/2016 by Catherine Saez, Intellectual Property Watch Leave a Comment Resistance to antibiotics by bacteria has been steadily growing and is now considered as a major threat to global public health, with some catastrophic projections of millions of death and billions of dollars in economic impact. The World Trade Organization, World Health Organization and World Intellectual Property Organization today are holding a joint technical symposium on antimicrobial resistance, and how to encourage innovation, appropriate use of antibiotics, and wide access to treatments and diagnostics.
Farm-Saved Seeds Sow Discord; Breeders, Users, Seek Clear Definition At UPOV 25/10/2016 by Catherine Saez, Intellectual Property Watch 1 Comment When a harvested material from a protected plant variety, such as seeds, is used for further sowing and cultivating, royalties need to be paid to the breeder of this protected variety. However, according to breeders, farm-saved seeds are sometimes used as an excuse to avoid paying royalties, and clear definitions should be established internationally. Conversely, small farmer associations think that once farmers buy a protected variety, they should be able to re-use those seeds, exchange or sell them. The International Union for the Protection of New Varieties of Plants (UPOV) organised a Seminar [pdf] on Propagating and Harvested Material in the Context of the UPOV Convention on 24 October.
From Personality To Property: Data Protection Needs Competition & Consumer Protection Law, Conference Says 25/10/2016 by Monika Ermert for Intellectual Property Watch 1 Comment MUNICH — Will personal data become a property right licensed to those who give you the best deal for it? Researchers at a conference convened by the Max Planck Institute for Innovation and Competition in Munich delved into a future “holistic approach” of intellectual property, data and consumer protection, with additional assistance from competition law.
Freedom To Utilize Genetic Resources? The Nagoya Protocol Two Years Later 24/10/2016 by Guest contributor for Intellectual Property Watch 1 Comment At its second anniversary, the Nagoya Protocol is ushering in an international access and benefit-sharing (ABS) system that may impact the freedom to operate with genetic resources. Those who utilize genetic resources and information should understand the emerging framework and take actions to reduce the risk of patent invalidation, legal liability and reputational harm that may flow from a violation of ABS requirements, writes Bruce S. Manheim.